Endoprosthesis for the treatment of type A aortic dissection

Original title: Application of Open Triple-Branch Aortic Arch Stent Graff for Acute Stanford Type A Aortic Dissection Reference: Fei Hua, et; al. Vascular Endovascular Surgery 47;2:109-14

Type A aortic dissection is a disease of high morbidity and mortality, especially in the early hours . Surgery is the treatment of choice but still have a significant complication rate .

We analyzed 34 patients with type A aortic dissection treated with branched stent for neck vessels ( Aortec Medical Technology Co Ltd , Beijing , China ) and were compared with 16 patients who underwent conventional surgery . No significant differences in baseline characteristics of both groups.

The procedure was performed under general anesthesia with median stereotomy, cardiopulmonary bypass , blood cardioplegia and deep hypothermia before implantation of the stent and its branches. The group that received stents had lower cardiopulmonary bypass time ( 186 ± 38 min . Versus 204 ± 47 min .), lower myocardial ischemic  time ( 101 ± 27 min . Versus 119 ± 30 min .) , shorter selective brain perfusion time ( 39 ± 11 min . Versus 46 ± 11 min . ) , as well as mechanical ventilation assistance  (19.9 ± 3.4 hours versus 20.4 ± 3.7 hours. ) And stay in intensive care (82.1 ± 11.2 hours. Versus  89.2 ± 13.1 hours.) During hospitalization 2 patients died, one required dialysis , 2 evolved with arm mobility impairments and one  presented consciousness disorders. At 9.6 months (2-24 months) follow-up , no patient died and only one had right arm motility difficulty  and required rehabilitation. Control tomography was performed in all patients witnessing a correct stent implantation with the preserved flow in the legs without significant leaks .

Conclusion:

This stent would be useful for those patients who require surgical reconstruction of the thoracic aorta , thus reducing the time of cardiopulmonary bypass from traditional surgery and potential complications thereof . 

Comment:

While this is a small population, indicates that it was possible to satisfactory solve, with this strategy favorably resolve such a complex disease , reducing surgical time and intensive areas and a good performance in the medium term. 

Courtesy by Dr Carlos Fava
Interventional Cardiologist
Favaloro Foundation
Buenos Aires – Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...